Page results
-
This information has been written for parents and carers whose child is having radiotherapy treatment to the whole lungs. The page explains the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the testes.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the chest, or mediastinum.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
File results
-
FOI/2022/0477 - The Integrated Care Board (ICB) that commissions services from Trust
-
FOI/2022/0478 - Hospital-initiated cancellation of appointments
-
FOI/2022/0481 - Electronic Patient Record system
-
FOI/2022/0482 - Non-emergency patient transport service (NEPTS)
-
FOI/2022/0485 - ACR laboratory device
-
FOI/2022/0486 - Dermatology dept staff details
-
FOI/2022/0487 - ICT spend on telecommunication, mobile handsets/ smartphones
-
FOI/2022/0488 - Robotic process automation
-
FOI/2022/0489 - Prescribed PrEP medication
-
FOI/2022/0494 - Treatment of Haemophilia A